What is the main business of Nova Centrum?

The main business activity of Nova Centrum focuses on dispensing chemist in specialised stores.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on January 15, 2002.

Where is the headquarters located?

The headquarters is located at: Bohaterów Warszawy 43, 78-400 Szczecinek.

What is the share capital?

The share capital of the company is PLN 50,000 (approx. $13,506).

What period do the latest financial data cover?

The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.

What revenue was generated?

The company reported a revenue of USD 1,081,595 in 2025, which is an increase of 8.2% compared to 2024.

Is the company profitable?

Yes, in 2025 the company was profitable, achieving a net profit of USD 69,528, meaning the company decreased its profit by 3.7%.

Which cost dominates operating expenses?

The largest operating cost category falls under cost of goods and materials sold. This category amounted to USD 804,785 in 2025, representing 81% of all operating expenses.

Nova Centrumsp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2002-01-15

Share capital

50,000.00 PLN

Activity description

Nova Centrum Sp. z o.o. is a pharmaceutical company founded in 1997 and converted to its current legal form in 2002. Its team of doctors and pharmacists has experience in pharmaceutical marketing and retail sales; the company offers the Ecometr ecological medical thermometer.

Registered address

Bohaterów Warszawy 43, 78-400 Szczecinek, Poland

Website

novacentrum.com.pl

Financials

Revenue history (in k)

Filing timeliness

4 of 6 financial statements were filed late (the longest delay 75 days for 2021).

202515/07/2026
202411/07/2025
202316/07/2024
202217/07/2023
202128/09/2022
202016/11/2021

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 1.08mMedianUSD 1.92mAverageUSD 5.20m

Net profit

This companyUSD 69.53kMedianUSD 20.66kAverageUSD 86.62k

Operating costs

This companyUSD 998.51kMedianUSD 1.88mAverageUSD 5.04m

Assets

This companyUSD 844.22kMedianUSD 544.32kAverageUSD 1.76m

Industry

Offer

Medical thermometer

Authorized Representatives

Mariusz Andrzej Zwierzyński – Attorney-in-fact (sole)

Małgorzata Danuta Chomej – President of the Management Board

Manner of representation

One-person representation.

Ownership

Owner	Shares	Share value	Stake
Małgorzata Danuta Chomejage 57	50	$6,753.11	50%
Agnieszka Wesołowskaage 58	50	$6,753.11	50%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2002-01-15.

Erste Bank Polska
48 1090 1711 0000 0001 2072 6966
Erste Bank Polska
53 1090 1711 0000 0001 3470 4576
Erste Bank Polska
65 1090 1711 0000 0001 2191 0642

Debt

No entries in the National Debtors Register (KRZ).

Real estate

Type	Amount
Land (incl. perpetual usufruct)	$24,937$24,937
Buildings and premises	$41,262$41,262

Public aid

4 public aid cases recorded, with a total value of $25,341.

Grant date	Purpose	Gross amount	Granting body
Jul 1, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	––	Polski Fundusz Rozwoju S.A.
Jun 20, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	––	Prezes Zakładu Ubezpieczeń Społecznych
May 30, 2020	Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts	––	Prezes Zakładu Ubezpieczeń Społecznych

Regulatory authorisations

Authority	Type	Status
BDO	BDO register entry	Active

Competitors

	Name	Revenue	Website
	Bio-Labsp. z o.o.	$320,999.14	bio-lab.com.pl

FAQ

Last updated: 2026-10-20